Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IND
Biotech
Makary FDA reforms ‘continue to move forward’ despite turmoil
Makary's namesake program, the controversial Commissioner’s National Priority Voucher, remains unchanged in name and direction, Fierce has learned.
Darren Incorvaia
May 26, 2026 10:27am
Denali ph. 1 Pompe plans hit with clinical hold
Dec 4, 2025 11:52am
FDA proposes higher fees for ph. 1 trials conducted outside of US
Dec 3, 2025 5:19pm
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
Empress' crown slips as biotech lays off over half of workers
Mar 18, 2025 1:20pm